Back
Trane Technologies PLC 10K Form
Buy
62
TT
Trane Technologies PLC
Last Price:
205.23
Seasonality Move:
0.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-02-18 | 10K | TT/Trane Technologies PLC Annual |
2019-10-29 | 10Q | TT/Trane Technologies PLC Quarterly |
2019-08-05 | 10Q | TT/Trane Technologies PLC Quarterly |
2019-05-01 | 10Q | TT/Trane Technologies PLC Quarterly |
2019-02-12 | 10K | TT/Trane Technologies PLC Annual |
2018-10-24 | 10Q | TT/Trane Technologies PLC Quarterly |
Receive TT News And Ratings
See the #1 stock for the next 7 days that we like better than TT
TT Financial Statistics
Sales & Book Value
Annual Sales: | $15.99B |
---|---|
Cash Flow: | $467.1M |
Price / Cash Flow: | 31.31 |
Annual Sales: | $27.45 |
Price / Book: | 7.49 |
Profitability
EPS (TTM): | 8.11000 |
---|---|
Net Income (TTM): | $1.88B |
Gross Margin: | $4.96B |
Return on Equity: | 31.38% |
Return on Assets: | 10.41% |
Trane Technologies PLC Earnings Forecast
Key Trane Technologies PLC Financial Ratios
- The Gross Profit Margin over the past 39 years for TT is 31.05%.
- The Selling, General & Administrative Expenses for TT have been equal to 15.92% of Gross Profit Margin.
- The Interest Expense is 12.72% of Operating Income.
- The Net Earning history of TT is 10.98% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 25 years.
Trane Technologies PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Building Products & Equipment |
Sector: | Industrials |
Current Symbol: | TT |
CUSIP: | G8994E |
Website: | tranetechnologies.com |
Debt
Debt-to-Equity Ratio: | 0.8 |
---|---|
Current Ratio: | 1.19 |
Quick Ratio: | 0.69 |
Price-to-Earnings
Trailing P/E Ratio: | 27.44 |
---|---|
Forward P/E Ratio: | 21.31 |
TT Technical Analysis vs Fundamental Analysis
Buy
62
Trane Technologies PLC (TT)
is a Buy
Is Trane Technologies PLC a Buy or a Sell?
-
Trane Technologies PLC stock is rated a Buy
The current Trane Technologies PLC [TT] share price is $205.23. The Score for TT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.